We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+3.56%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.83%
AUM
$21.5B
AUM Growth
+$3.38B
(+19%)
Cap. Flow
+$3.03B
Cap. Flow
% of AUM
14.11%
Top 10 Holdings %
Top 10 Hldgs %
7.31%
Holding
3,174
New
981
Increased
805
Reduced
803
Closed
576
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.24% |
| 2 | Technology | 10.83% |
| 3 | Industrials | 10.74% |
| 4 | Healthcare | 10.45% |
| 5 | Financials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDLI
376
DELISTED
PDL BioPharma, Inc.
PDLI
| $13.5M | 0.06% |
1,923,393
+1,856,872
| +2,791% | +$13.4M |
|
377
Principal Financial Group
PFG
$24.3B
| $13.5M | 0.06% |
262,907
-96,976
| -27% | -$4.87M |
|
378
PUT
Kinder Morgan
KMI
$71.7B
| $13.5M | 0.06% |
+321,000
| New | +$13.3M |
|
|
GES
379
DELISTED
Guess Inc
GES
| $13.5M | 0.06% |
724,031
+445,944
| +160% | +$8.42M |
|
380
ProShares UltraPro QQQ
TQQQ
$32.1B
| $13.4M | 0.06% |
6,264,000
+5,265,600
| +527% | +$11.2M |
|
|
LXFT
381
DELISTED
Luxoft Holding, Inc.
LXFT
| $13.4M | 0.06% |
259,605
+32,146
| +14% | +$1.47M |
|
382
Procter & Gamble
PG
$336B
| $13.4M | 0.06% |
+163,586
| New | +$14.1M |
|
|
CYT
383
DELISTED
CYTEC INDS INC
CYT
| $13.4M | 0.06% |
247,395
-70,548
| -22% | -$3.52M |
|
|
HNT
384
DELISTED
HEALTH NET INC
HNT
| $13.3M | 0.06% |
220,295
-86,250
| -28% | -$4.86M |
|
|
WSTC
385
DELISTED
West Corporation
WSTC
| $13.3M | 0.06% |
394,615
+337,911
| +596% | +$11.2M |
|
386
Smith & Nephew
SNN
$13.3B
| $13.3M | 0.06% |
388,814
+90,000
| +30% | +$3.18M |
|
387
Ryder
R
$9.83B
| $13.2M | 0.06% |
+139,441
| New | +$12.8M |
|
388
Liberty Media Series A
FWONA
$22.5B
| $13.1M | 0.06% |
507,216
-69,787
| -12% | -$1.74M |
|
389
Abercrombie & Fitch
ANF
$4.42B
| $13.1M | 0.06% |
593,924
-134,901
| -19% | -$3.33M |
|
|
X
390
DELISTED
US Steel
X
| $13.1M | 0.06% |
535,409
-171,615
| -24% | -$4.07M |
|
391
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $13M | 0.06% |
+63,100
| New | +$13M |
|
|
MNK
392
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $13M | 0.06% |
102,758
+5,437
| +6% | +$621K |
|
|
ANDV
393
DELISTED
Andeavor
ANDV
| $13M | 0.06% |
142,046
-381,993
| -73% | -$32M |
|
|
BMS
394
DELISTED
Bemis
BMS
| $13M | 0.06% |
279,675
+184,608
| +194% | +$8.57M |
|
|
TW
395
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $12.9M | 0.06% |
97,938
-23,904
| -20% | -$3M |
|
|
ESPR
396
DELISTED
Esperion Therapeutics
ESPR
| $12.9M | 0.06% |
138,983
+100,733
| +263% | +$6.5M |
|
397
Oneok
OKE
$57.2B
| $12.8M | 0.06% |
265,604
-552,516
| -68% | -$25.2M |
|
398
UDR
UDR
$12.3B
| $12.8M | 0.06% |
375,097
+11,664
| +3% | +$383K |
|
399
Microchip Technology
MCHP
$40.3B
| $12.7M | 0.06% |
517,778
-217,138
| -30% | -$5.24M |
|
400
Stryker
SYK
$125B
| $12.6M | 0.06% |
+136,411
| New | +$12.7M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2015 Portfolio in Review
As of Q1 2015, Two Sigma Investments held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
Two Sigma Investments deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 9.6% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- Two Sigma Investments's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- Two Sigma Investments added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- Two Sigma Investments's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- Two Sigma Investments fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- Two Sigma Investments's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- Two Sigma Investments opened 981 new positions and closed 576 in Q1 2015.
- Two Sigma Investments's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.